Elevated A2F bisect N-glycans of serum IgA reflect progression of liver fibrosis in patients with MASLD
Journal of Gastroenterology · 2025
DOI: 10.1007/s00535-024-02206-8 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Gastroenterology, 2025. Verfasst von Hisatoshi Hanamatsu und 20 weiteren Autor:innen. Beteiligte Einrichtung: Institute for Glyco-Core Research (iGCORE), Nagoya University, Aichi, Japan. Hauptthemen laut MEDLINE: Liver Cirrhosis, Polysaccharides, Immunoglobulin A, Fatty Liver. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 53 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Japan Agency for Medical Research and Development, Nagoya University.
Abstract (Originalsprache)
Background
Advanced liver fibrosis in cases of metabolic dysfunction-associated steatotic liver disease (MASLD) leads to cirrhosis and hepatocellular carcinoma. The current gold standard for liver fibrosis is invasive liver biopsy. Therefore, a less invasive biomarker that accurately reflects the stage of liver fibrosis is highly desirable.
Methods
This study enrolled 269 patients with liver biopsy-proven MASLD. Patients were divided into three groups (F0/1 ( n = 41/85), F2 ( n = 47), and F3/4 ( n = 72/24)) according to fibrosis stage. We performed serum N -glycomics and identified glycan biomarker for fibrosis stage. Moreover, we explored the carrier proteins and developed a sandwich ELISA to measure N -glycosylation changes of carrier protein.
Results
Comprehensive N -glycomic analysis revealed significant changes in the expression of A2F bisect and its precursors as fibrosis progressed. The sum of neutral N -glycans carrying bisecting GlcNAc and core Fuc (neutral sum) had a better diagnostic performance to evaluate advanced liver fibrosis (AUC = 0.804) than conventional parameters (FIB4 index, aspartate aminotransferase-to-alanine aminotransferase ratio (AAR), and serum level of Mac-2-binding protein glycol isomer (M2BPGi). The combination of the neutral sum and FIB4 index enhanced diagnostic performance (AUC = 0.840). IgM, IgA, and complement C3 were identified as carrier proteins with A2F bisect N -glycan. A sandwich ELISA based on N -glycans carrying bisecting GlcNAc and IgA showed similar diagnostic performance than the neutral sum.
Conclusions
A2F bisect N -glycan and its precursors are promising candidate biomarkers for advanced fibrosis in MASLD patients. Analysis of these glycan alterations on IgA may have the potential to serve as a novel ELISA diagnostic tool for MASLD in routine clinical practice. Clinical trial number UMIN000030720.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Institute for Glyco-Core Research (iGCORE), Nagoya University, Aichi, Japan.
- Department of Gastroenterology and Hepatology, Graduate School of Medicine, Hokkaido University, Hokkaido, Japan.
- Department of Gastroenterology and Hepatology, Musashino Red Cross Hospital, Tokyo, Japan.
- Department of Gastroenterology and Hepatology, Osaka University Graduate School of Medicine, Osaka, Japan.
- Department of Gastroenterology, Faculty of Medicine, Yamagata University, Yamagata, Japan.
- First Department of Internal Medicine, Faculty of Medicine, University of Yamanashi, Yamanashi, Japan.
Förderung
- Japan Agency for Medical Research and Development
- Nagoya University
Zitieren
APA
Hanamatsu, H., Suda, G., Ohara, M., Ogawa, K., Tamaki, N., Hikita, H., Haga, H., Maekawa, S., Sugiyama, M., Kakisaka, T., Nakai, M., Sho, T., Miura, N., Kurosaki, M., Asahina, Y., Taketomi, A., Ueno, Y., Takehara, T., Nishikaze, T., …, & Sakamoto, N. (2025). Elevated A2F bisect N-glycans of serum IgA reflect progression of liver fibrosis in patients with MASLD. Journal of Gastroenterology. https://doi.org/10.1007/s00535-024-02206-8
Vancouver
Hanamatsu H, Suda G, Ohara M, Ogawa K, Tamaki N, Hikita H, et al. Elevated A2F bisect N-glycans of serum IgA reflect progression of liver fibrosis in patients with MASLD. Journal of Gastroenterology. 2025. doi:10.1007/s00535-024-02206-8
BibTeX
@article{Hanamatsu2025,
author = {Hanamatsu, Hisatoshi and Suda, Goki and Ohara, Masatsugu and Ogawa, Koji and Tamaki, Nobuharu and Hikita, Hayato and Haga, Hiroaki and Maekawa, Shinya and Sugiyama, Masaya and Kakisaka, Tatsuhiko and Nakai, Masato and Sho, Takuya and Miura, Nobuaki and Kurosaki, Masayuki and Asahina, Yasuhiro and Taketomi, Akinobu and Ueno, Yoshiyuki and Takehara, Tetsuo and Nishikaze, Takashi and Furukawa, Jun-Ichi and Sakamoto, Naoya},
title = {Elevated A2F bisect N-glycans of serum IgA reflect progression of liver fibrosis in patients with MASLD},
journal = {Journal of Gastroenterology},
year = {2025},
doi = {10.1007/s00535-024-02206-8}
}
EUVIMED